Literature DB >> 34674182

Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments.

Seungyong Shin1,2, Jiyoung Lee3, Jieun Han1,2, Fangyuan Li3,4, Daishun Ling3,5, Wooram Park6,7.   

Abstract

Cancer is one of the major diseases that threaten human life worldwide. Despite advances in cancer treatment techniques, such as radiation therapy, chemotherapy, targeted therapy, and immunotherapy, it is still difficult to cure cancer because of the resistance mechanism of cancer cells. Current understanding of tumor biology has revealed that resistance to these anticancer therapies is due to the tumor microenvironment (TME) represented by hypoxia, acidity, dense extracellular matrix, and immunosuppression. This review demonstrates the latest strategies for effective cancer treatment using functional nanoparticles that can modulate the TME. Indeed, preclinical studies have shown that functional nanoparticles can effectively modulate the TME to treat refractory cancer. This strategy of using TMEs with controllable functional nanoparticles is expected to maximize cancer treatment efficiency in the future by combining it with various modern cancer therapeutics.
© 2021. The Korean Tissue Engineering and Regenerative Medicine Society.

Entities:  

Keywords:  Biomaterials; Cancer treatments; Drug delivery; Nanoparticles; Tumor microenvironment

Mesh:

Year:  2021        PMID: 34674182      PMCID: PMC8971234          DOI: 10.1007/s13770-021-00403-7

Source DB:  PubMed          Journal:  Tissue Eng Regen Med        ISSN: 1738-2696            Impact factor:   4.451


  83 in total

1.  Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

Authors:  Arianna Calcinotto; Paola Filipazzi; Matteo Grioni; Manuela Iero; Angelo De Milito; Alessia Ricupito; Agata Cova; Rossella Canese; Elena Jachetti; Monica Rossetti; Veronica Huber; Giorgio Parmiani; Luca Generoso; Mario Santinami; Martina Borghi; Stefano Fais; Matteo Bellone; Licia Rivoltini
Journal:  Cancer Res       Date:  2012-05-16       Impact factor: 12.701

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

4.  Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy.

Authors:  Yu-Xue Zhang; Yang-Yang Zhao; Jizhou Shen; Xun Sun; Yi Liu; Hang Liu; Yucai Wang; Jun Wang
Journal:  Nano Lett       Date:  2019-04-05       Impact factor: 11.189

5.  Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.

Authors:  Clifford J Whatcott; Haiyong Han; Richard G Posner; Galen Hostetter; Daniel D Von Hoff
Journal:  Cancer Discov       Date:  2011-09       Impact factor: 39.397

6.  LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.

Authors:  Almut Brand; Katrin Singer; Gudrun E Koehl; Marlene Kolitzus; Gabriele Schoenhammer; Annette Thiel; Carina Matos; Christina Bruss; Sebastian Klobuch; Katrin Peter; Michael Kastenberger; Christian Bogdan; Ulrike Schleicher; Andreas Mackensen; Evelyn Ullrich; Stefan Fichtner-Feigl; Rebecca Kesselring; Matthias Mack; Uwe Ritter; Maximilian Schmid; Christian Blank; Katja Dettmer; Peter J Oefner; Petra Hoffmann; Stefan Walenta; Edward K Geissler; Jacques Pouyssegur; Andreas Villunger; André Steven; Barbara Seliger; Stephan Schreml; Sebastian Haferkamp; Elisabeth Kohl; Sigrid Karrer; Mark Berneburg; Wolfgang Herr; Wolfgang Mueller-Klieser; Kathrin Renner; Marina Kreutz
Journal:  Cell Metab       Date:  2016-09-15       Impact factor: 27.287

7.  Role of extracellular matrix assembly in interstitial transport in solid tumors.

Authors:  P A Netti; D A Berk; M A Swartz; A J Grodzinsky; R K Jain
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

8.  Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.

Authors:  Deby F Mardhian; Gert Storm; Ruchi Bansal; Jai Prakash
Journal:  J Control Release       Date:  2018-10-02       Impact factor: 9.776

9.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

Review 10.  New opportunities for nanoparticles in cancer immunotherapy.

Authors:  Wooram Park; Young-Jae Heo; Dong Keun Han
Journal:  Biomater Res       Date:  2018-09-26
View more
  2 in total

1.  Nano-sized Materials for Tissue Regeneration and Immune/Cancer Therapy.

Authors:  Suk Ho Bhang; Inho Jo
Journal:  Tissue Eng Regen Med       Date:  2022-04       Impact factor: 4.169

2.  Highly tailorable gellan gum nanoparticles as a platform for the development of T cell activator systems.

Authors:  Daniel B Rodrigues; Helena R Moreira; Mariana T Cerqueira; Alexandra P Marques; António G Castro; Rui L Reis; Rogério P Pirraco
Journal:  Biomater Res       Date:  2022-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.